Skip to main content

A Review of the Use of Anti-vascular Endothelial Growth Factor Drugs at the Eye Foundation Centre for the Prevention of Blindness, Nigeria | Chapter 06 | New Insights into Disease and Pathogen Research Vol. 3

Aims: To describe the sociodemographic details and indications for the use of anti-vascular endothelial growth factor (anti-VEGF) injections at the Eye Foundation Centres in Nigeria.

Study Design:
Retrospective, observational analysis.

Place and Duration of Study:
Eye Foundation Hospitals in Lagos, Ijebu-Imushin and Abuja, Nigeria between January 2011 and December 2014.

Records of all anti-VEGF injections given were assessed. All consecutive cases were taken in proportion seen in the 4 centres. Age, sex, occupation, diagnoses and types of injection were recorded in the data sheet prepared for the study.

Results: This study included 1072 eyes of 540 patients. Mean age was 60.37(12.74) standard deviation years. The age range is from 10 – 92 years. 326(60.4%) males and females 214(39.6%) were seen. Patients that presented were mostly currently employed 40.8%, previously in paid job 25.8% and businessmen and women 24.5%. Total injections were 2443, given during the study period. Anti-VEGF agents used were Bevacizumab (2278; 93.2%) and Ranibizumab (165; 6.8%).

Indications for injection were:
proliferative diabetic retinopathy (PDR) 27.4%, retinal vein occlusion (RVO) 17.6% and vitreous haemorrhage (VH) due to proliferative diabetic retinopathy and sickle cell retinopathy 10.6%. There was an association between sex and disease (p < 0.001) and age and disease (p < 0.001).

The use of anti-VEGF injections are on the increase especially bevacizumab. The most common indications are proliferative diabetic retinopathy, retinal vein occlusion and VH. The treatment was done more for males, middle class and the rich.

Author(s) Details

Tayo Julius Bogunjoko
Eye Foundation Centre for the Prevention of Blindness, Nigeria.

Dr. Adekunle Hassan, MD. FRCS, FRCOph, FWACS, FNICM
Eye Foundation Centre for the Prevention of Blindness, Nigeria.

Dr. Olufemi Oderinlo
Eye Foundation Centre for the Prevention of Blindness, Nigeria.

Okonkwo Ogugua
Eye Foundation Centre for the Prevention of Blindness, Nigeria.

Mildred Ulaikere
Eye Foundation Centre for the Prevention of Blindness, Nigeria.

Toyin Akanbi
Eye Foundation Centre for the Prevention of Blindness, Nigeria.

Abimbola Ashaye
Eye Foundation Centre for the Prevention of Blindness, Nigeria.

View Books:


Popular posts from this blog

Use of the Arrhenius Equation in Kinetic Analyses and Mathematical Modeling of Rate Data Requires the Most Precise, Even Scrupulous, Application and Term Definitions | Chapter 6 | Theory and Applications of Chemistry Vol. 2

This article presents a critical analysis of the frequent practice of using the Arrhenius equation for mathematical modeling of very many physical and chemical rate processes. This approach may also be used to characterize the controls and mechanisms of the rate processes investigated. We also discuss  the  specific  form  of  the Arrhenius-type  equation  as  a  relationship  meriting  detailed investigations. In our opinion, the use of the Arrhenius relationship often can only approximate to the behavior of such systems, exemplified by the systems discussed below, including the work of N N Semenov, A K Galwey, A G Mershanov, etc. We draw attention to "erroneous" experimental designs, including the so-called "global kinetic mechanism" and other widespread uses of theoretical models which do not necessarily represent the real situation. Such limitations in rate data analyses impact negatively throughout this branch of science. Here we attempt to question these ac

A Brief Study of Middleware Technologies: Programming Applications and Management Systems | Chapter 15 | Novel Research Aspects in Mathematical and Computer Science Vol. 1

  Many platforms, services, applications, hardware, and operating systems are connected through the middleware layer. Because the middleware layer abstracts much low-level complexity and makes applications and software systems portable, it allows disparate systems to interface and function together in harmony. Middleware technologies enable software engineers to swiftly construct software systems and applications, allowing developers to focus on more important tasks. This chapter examines several types of middleware systems and discusses middleware capabilities, middleware operation, middleware's function in cloud-based systems, and the best middleware platforms to use. Middleware systems are widely utilised and can be found in practically any software system or application. Middleware programmes provide as a link between many sorts of systems and protocols. They serve as a mechanism for various systems. To successfully exchange information, it runs on a variety of operating system

A Facility-based Assessment of Internalized Stigma among Patients with Severe Mental Illnesses in Maiduguri, North-Eastern Nigeria | Chapter 05 | Emerging Research in Medical Sciences Vol. 3

Introduction: Public stigmatization of mental illnesses might lead to the internalization of the stigma by persons with mental illness (PWMIs) which might also lead to erosion of self-esteem and negative consequences on treatment outcome. This study assessed the prevalence of internalized stigma and analyzed its socio-demographic and clinical predictors among PWMIs in a sub-Saharan African mental health facility. Methods: Patients with schizophrenia, bipolar disorder and severe depression (n = 370) were randomly interviewed at the out-patient department of the Federal Neuropsychiatric Hospital, Maiduguri. They completed the sociodemographic and clinical proformata, Oslo social support scale, and an adapted version of the internalized stigma of mental illness scale (ISMI). Results: A total of 83 subjects (22.5%) met the study's criterion score for high internalized stigma. The independent predictors of high internalized stigma were; poor social support (Odds ratio, OR =